Investors Overview

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs.

Annual Reports

2017 Annual Report

Financial Reports

Quarterly Reports

Events & Webcasts

View a listing of our recent events and webcasts

Tuesday, March 19, 2019
8:30am EDT

DIAL IN NUMBER: (416) 764-8609 or (888) 390-0605
CONFERENCE ID: 05671895
REPLAY: (888) 390-0541 (playback code 671895)
Available until midnight (EDT) March 26, 2019